News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Cancer Therapy Advisor – Results, from the STARGLO trial presented at EHA2024 by Dr Jeremy Abramson
Photo taken from researchers.mgh.harvard.edu
Jun 21, 2024, 07:58

Cancer Therapy Advisor – Results, from the STARGLO trial presented at EHA2024 by Dr Jeremy Abramson

Cancer Therapy Advisor shared a post on X:

“Glofitamab plus GemOx improved outcomes over rituximab plus GemOx in transplant-ineligible patients with relapsed/refractory DLBCL. These results, from the STARGLO trial, were presented at EHA2024 by Dr Jeremy Abramson from Mass General Cancer Center.”

Read further.
Source: Cancer Therapy Advisor/X

cancer Cancer Therapy Advisor EHA2024 Jeremy Abramson Mass General Cancer Center OncoDaily Oncology
Special Coverage
Blog
Dec 2, 2024, 12:32
Saved money? Save lives - National Foundation for Cancer Research
Insight
Dec 2, 2024, 12:31
10 presentations not to miss from SABCS 2024 sugested by Paolo Tarantino
Blog
Dec 2, 2024, 12:23
Karen Knudsen: Honoring an Unsung Chemist, Dora Richardson, Who Transformed Cancer Care
Blog
Dec 2, 2024, 10:22
Tejas Patil: The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in non-small cell lung cancer
Blog
Dec 2, 2024, 10:01
Women, Power, and Cancer: my latest interview with ecancer - Ophira Ginsburg
Blog
Dec 2, 2024, 09:57
Michael Shusterman: GI Oncology standard regimen doses remain too high for many real world patients
Positive
Dec 2, 2024, 09:46
Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024
Blog
Dec 2, 2024, 09:07
Support Children Battling Cancer and their Parents with The Goodwill Foundation - Onco Intelligence
Blog
Dec 2, 2024, 09:04
How can mpMRI change management of patients with NMIBC or MIBC?
Blog
Dec 2, 2024, 08:15
Nikhil Vojjala: Excited to win the Michigan state ACP Doctors dilemma championship
Insight
Dec 2, 2024, 08:12
Mattia Rediti: Our work describing HER2-positive Breast Cancer heterogeneity is out
Insight
Dec 2, 2024, 08:01
Enrique Soto: Our systematic review on the use of wearable technologies in older adults with Cancer